clinical trial · NCT04427241
Efficacy and Safety of Cerebrolysin on Prolonged Disorders of Consciousness
Konkuk University Medical Center·phase4·unknown·n = 12
Disorder of ConsciousnessHemorrhagic StrokeCerebrolysinControl
brief summary
Object: To determine the effect of cerebrolysin on prolonged disorders of consciousness caused by hemorrhagic stroke. Participants: patients with prolonged disorders of consciousness due to severe traumatic brain injury Intervention: 30 ml cerebrolysin + 70 ml normal saline, days 4-17, once/day, intravenously or 100 ml normal saline, days 4-17, once/day, IV Comparison: cerebrolysin group versus control group Outcome: Coma Recovery Scale-revised, FDG-PET signal
started
Jun 1, 2023
primary completion
Jul 31, 2025
completion
Dec 31, 2025
last updated
May 26, 2023
official title
Efficacy and Safety of Cerebrolysin on Prolonged Disorders of Consciousness in Patients With Hemorrhagic Stroke: A Pilot Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol